Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-tumor Chinese medicinal composition and preparation method thereof

A composition and anti-tumor effect technology, applied in anti-tumor drugs, drug combinations, pharmaceutical formulas, etc., to achieve the effects of adjuvant radiotherapy and chemotherapy, definite curative effect, and rich raw material resources

Active Publication Date: 2010-06-09
JIANGZHONG PHARMA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is mainly used to treat all kinds of cancers caused by long-term stagnation of phlegm and dampness, blood stasis, blood flow stagnation, phlegm and blood stasis, and various cancers. Warming and appetizing, dredging collaterals and promoting stagnation, promoting blood circulation and removing stasis, reducing swelling and dissipating stagnation, clearing away heat and detoxification; there is no anti-tumor composition composed of astragalus, ginseng, Atractylodes macrocephala, wolfberry and fermented Cordyceps powder

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Take 20 parts of astragalus, 15 parts of ginseng, 10 parts of Atractylodes macrocephala, 10 parts of medlar, 5 parts of fermented cordyceps fungus powder, 20 parts of ginseng, 20 parts of golden buckwheat, 20 parts of Hedyotis diffusa, 5 parts of Panax notoginseng, 5 parts of Sappan Add water and decoct three times, each time for 1 hour, add 12 times the amount of water for the first time, add 10 times the amount of water for the second and third times, filter, combine the water extracts, concentrate under reduced pressure to a relative density of 1.05-1.15, and the temperature is 60°C , add an appropriate amount of dextrin, spray dry, and the obtained powder is granulated in one step to make granules.

Embodiment 2

[0044] Take 10 parts of astragalus, 20 parts of ginseng, 5 parts of Atractylodes macrocephala, 20 parts of medlar, 1 part of fermented Cordyceps fungus powder, 30 parts of ginseng, 10 parts of golden buckwheat, 30 parts of Hedyotis diffusa, 10 parts of Panax notoginseng, 1 part of sumac Add water and decoct three times, each time for 1 hour, add 12 times the amount of water for the first time, add 10 times the amount of water for the second and third times, filter, combine the water extracts, concentrate under reduced pressure to a relative density of 1.05-1.15, and the temperature is 60°C , add an appropriate amount of dextrin, spray dry, and the obtained powder is granulated in one step to make granules.

Embodiment 3

[0046] Take 30 parts of astragalus, 5 parts of ginseng, 20 parts of Atractylodes macrocephala, 5 parts of medlar, 10 parts of fermented cordyceps fungus powder, 10 parts of fist ginseng, 30 parts of golden buckwheat, 10 parts of Hedyotis diffusa, 1 part of Panax notoginseng, 10 parts of hematoxylin Add water and decoct three times, each time for 1 hour, add 12 times the amount of water for the first time, add 10 times the amount of water for the second and third times, filter, combine the water extracts, concentrate under reduced pressure to a relative density of 1.05-1.15, and the temperature is 60°C , add an appropriate amount of dextrin, spray dry, and the obtained powder is granulated in one step to make 1000g granules. Usage and dosage: Take after mixing, 10g each time, 2 times a day.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to Chinese medicinal compositions, in particular to a Chinese medicinal composition inhibiting growth of a plurality of tumors, and also relates to a method for preparing the composition and application thereof. The composition comprises the following components in part by weight: 9 to 60 parts of astragalus, 2 to 20 parts of ginseng, 4 to 30 parts of largehead atractylodes rhizome, 5 to 30 parts of medlar and 1 to 10 parts of zymotic cordyceps militaris powder. The composition also comprises one or more components of 3 to 30 parts of bistort rhizome, 10 to 50 parts of wild buckwheat rhizome, 8 to 40 parts of spreading hedyotis herb, 1 to 20 parts of sappan wood, and 1 to 10 parts of sanchi.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for inhibiting the growth of various tumors, and also relates to a preparation method and application of the composition. technical background [0002] Tumor is one of the main diseases affecting human health at present. Chinese medicine has gradually shown its superiority in the combined prevention and treatment of tumors, especially in improving the survival rate and quality of life of patients. A large number of clinical and experimental research work has shown the research results in this area. Modern medicine focuses on eliminating local lesions and cancer cells in tumor research. During surgery, radiotherapy, and chemotherapy, it causes considerable damage to the body; In terms of evaluation, if we only take into account the growth and decline of the cancer focus, regardless of the overall state of the patient, it will ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/815A61P37/02A61P35/00
Inventor 易敏之李诒光夏春保钟虹光喻萍马莉吕毅斌卢建中
Owner JIANGZHONG PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com